By Felix Light
ANASEULI, Georgia (Reuters) -When Lika Megreladze was a child, life in her native western Georgian region of Guria revolved around tea.
Her mother worked for decades as a scientist at the Soviet Union’s Institute of Tea and Subtropical Crops in the village of Anaseuli, perfecting cultivation methods for a Georgian tea industry that supplied the bulk of the vast communist state’s brews.
“When I was a child, this... (continue reading...)
(Reuters) -European shares rose on Friday, on course for small weekly gains, as investors focussed on corporate earnings for clues on the impact of U.S. tariff policies on businesses.
The pan-European STOXX 600 index rose 0.3% to 548.84 points, as of 0731 GMT, and was on track for a second weekly gain.
Other major regional indexes, including the German DAX, France's CAC 40 and Britain's FTSE 100 also rose modestly.
Wall Street... (continue reading...)
BEIRUT (Reuters) -Syrian security forces are preparing to redeploy to the Druze-majority Sweida city to quell fighting with Bedouin tribes, a Syrian interior ministry spokesperson said on Friday, further straining a fragile truce in Syria's south.
A ceasefire announced on Wednesday briefly ended days of bloody fighting that erupted when Bedouin and Druze fighters clashed in Sweida province, prompting the Syrian government to send in troops - further... (continue reading...)
(Reuters) -Slice and dice it anyway you like and the week ahead for world markets will likely be dominated by politics and central banks in some shape or form.
Japan votes, the European Central Bank holds its pre-summer break policy meeting, U.S. President Donald Trump's constant pressure on the Federal Reserve chief stays on the watch list and Turkey's central bank meets against a backdrop of domestic political uncertainty.
Here's your... (continue reading...)
(Reuters) -GSK shares fell more than 6% on Friday after a U.S. FDA advisory panel recommended against approving its blood cancer drug Blenrep, citing earlier concerns over eye-related side effects.
The British drugmaker was trying to revive the drug, which was pulled from U.S. markets in 2022 after failing a late-stage study. GSK's renewed application is based on two late-stage trials showing that Blenrep, when used in combination, improved overall... (continue reading...)
More Reuters
View Older Stories-
China expected to keep lending rates steady, focus turns to Politburo meet
-
Taiwan will not provoke confrontation with China; does not seek conflict
-
Philippines' Marcos to discuss trade and security during U.S. visit as tariffs loom
-
PBOC governor, Bank of America senior executive discuss economy, financial markets
-
German home building permits decline in May as sector struggles
-
Indonesia still negotiating details, exemptions on U.S. tariff deal, official says
-
EU agrees 18th sanctions package against Russia
-
Russian forces take control of three Ukrainian villages across multiple regions, defence ministry says
-
Reckitt sells Essential Home stake to Advent for $4.8 billion
-
Burberry shows early signs of recovery as first quarter sales fall less than expected
-
German producer prices fall 1.3% y/y in June
-
Qatar-backed Mayhoola denies report it is considering Valentino sale with Kering
-
Defence group Saab beats profit forecast, raises 2025 outlook
-
Swedish defence group Saab reports Q2 profit above forecast
-
Electrolux Q2 profit rises more than expected as it outperforms market in North America
-
Electrolux Q2 profit rises more than expected as it outperforms market in North America
-
Electrolux beats expectations in Q2 as it outperforms in North America, offsets tariffs
-
Electrolux Q2 profit rises more than expected as it outperforms market in North America
-
Electrolux Q2 profit rises more than expected as it outperforms market in North America
-
Electrolux Q2 profit rises more than expected as it outperforms market in North America
-
Electrolux Q2 profit rises more than expected as it outperforms market in North America
-
Electrolux Q2 profit rises more than expected as it outperforms market in North America
-
Electrolux Q2 profit rises more than expected as it outperforms market in North America
-
Electrolux Q2 profit rises more than expected as it outperforms market in North America
-
Electrolux Q2 profit rises more than expected as it outperforms market in North America
-
Electrolux Q2 profit rises more than expected as it outperforms market in North America
-
Electrolux Q2 profit rises more than expected as it outperforms market in North America
-
Electrolux Q2 profit rises more than expected as it outperforms market in North America
-
Electrolux Q2 profit rises more than expected as it outperforms market in North America
-
Electrolux Q2 profit rises more than expected as it outperforms market in North America
-
Electrolux Q2 profit rises more than expected as it outperforms market in North America
-
Electrolux Q2 profit rises more than expected as it outperforms market in North America
-
Electrolux Q2 profit rises more than expected as it outperforms market in North America
-
Japan's markets brace for election impact on JGBs, yen
-
Japan's markets brace for election impact on JGBs, yen
-
Japan's markets brace for election impact on JGBs, yen
-
Japan's markets brace for election impact on JGBs, yen
-
Japan's markets brace for election impact on JGBs, yen
-
Japan's markets brace for election impact on JGBs, yen
-
Japan's markets brace for election impact on JGBs, yen
-
Japan's markets brace for election impact on JGBs, yen
-
Japan's markets brace for election impact on JGBs, yen
-
Japan's markets brace for election impact on JGBs, yen
-
Indian Apple reseller Ample to grow revenue by a third as it expands presence, portfolio, CEO says
-
Analysis-Foreign investors are warming to London's unloved stocks
-
US sides with Argentina in YPF dispute, investors suggest alternative collateral
-
China's spy agency attacks foreign efforts to 'steal' rare earths
-
Morning Bid: Stocks buoyant but Japan vote brings risk
-
China commerce minister discussed foreign investment, AI at meet with Nvidia CEO
-
China says successful US trade talks make return to tariff war unnecessary
